You are here
Gold Standard Articles of Interest for Diagnosis, Treatment Planning & Care
Bankhead, Charles. "PCPs Seek Identity in Cancer Survivor Care." Medpage Today, June 10, 2020.
A professional identity crisis has begun to emerge among primary care clinicians regarding their role in caring for cancer survivors, authors of a survey of physicians, nurses, and physician assistants (PAs) concluded.
Survey participants had widely divergent views regarding primary care's role in cancer survivor care and about the concept of survivorship. A few providers said responsibility for follow-up after acute care belonged entirely to oncology. Alternatively, some respondents viewed cancer survivors as no different from other patients with chronic conditions.
NCI Staff. "Helping Cancer Survivors Cope with Cancer-Related Anxiety and Distress." National Cancer Institute, April 30, 2020.
Being diagnosed with cancer and going through intensive treatment is stressful. So, when treatment ends, family and friends are eager to celebrate. But many cancer survivors don’t feel like celebrating or don’t feel ready to move on with their lives.
Ladarian, MD, Bahar. "Documented: Effects of Cancer Treatment on Employment." MedPage Today, February 18, 2020.
A recent study addressed the need for attention to breast cancer survivors after surgery, chemotherapy, and/or radiation to shed light on the adverse effects of treatment on employment. The hope was that knowing the results could better prepare patients and healthcare providers as well as employers and policymakers.
Lawrence, Leah. "Severe Health Issues Lay Ahead for Many Young Cancer Survivors." MedPage Today, February 14, 2020.
Compared with the general population, young cancer survivors were far more likely to develop severe and life-threatening health conditions in later life, and faced a significantly higher risk of death, data from a large retrospective study indicated.
Bassett, Mike. "How to get more men in breast cancer trials?." MedPage Today, October 8, 2019.
The FDA recently drafted new recommendations encouraging the inclusion of more men in breast cancer clinical trials.
The industry draft guidance urges that eligibility for breast cancer drugs should include both men and women, and that there should be a scientific rationale included in a trial protocol when men are excluded from trials.
Douglas R. Lowry, MD. "Future Directions in Cancer Survivorship and Aging." Coping with Cancer, July/August 2019.
Declining cancer deaths … More survivors living longer … An exciting time in cancer research and care …
Although these statements may sound like echoes of what we’ve been saying for several years, they’re not. The landscape of cancer research and care is constantly changing – and for the better.
Mike Fillon. "Greater support and resources needed for cancer survivors returning to work." Wiley Online Library, April 26, 2019.
A new Canadian study published in Psychooncology (2019;28:792‐798. doi:10.1002/pon.5021) reports that cancer survivors face a range of problems in the workplace, including stigma and misperceptions about their abilities; a higher risk of losing their job compared with healthy controls; a lack of understanding regarding their work abilities, productivity, and reliability; and costs associated with their continued employment.
"Making Cancer Clinical Trials Available to More Patients." NCI Cancer Currents Blog, March 7, 2019.
With so many new and promising cancer treatments being developed, the need for clinical trials to efficiently and effectively test them has never been greater.
Maximizing the number of patients who are eligible for clinical trials, while still maintaining an appropriate level of safety, is a top priority for NCI leadership, given the challenges of enrolling enough patients in clinical trials. Eligibility criteria—the requirements that must be met before a person can enroll in a trial—have not kept pace with the modernization of clinical trials. Restrictive criteria have not only been a significant hurdle for many patients who have wanted to participate in trials, but they have also limited the generalizability of study findings.
Pirschel, Chris and Sheila Prindiville, MD. "How Do You Find Clinical Trials Through the NCI’s Advanced Clinical Trials Search?." ONS Voice, September 5, 2017.
As part of the National Cancer Moonshot Initiative and in collaboration with the Presidential Innovation Fellows, the National Cancer Institute (NCI) developed and launched a new website in 2016. It provides user-friendly access to the repository of abstracts of cancer clinical trials that NCI supported.
Tedeschi, Bob. "McCain is considered a warrior. But is that the right metaphor for his struggle with cancer?." STAT, July 21, 2017.
Moments after the news of Sen. John McCain’s brain tumor reached the internet, he was being pinned with the badge of the cancer warrior. And while arguably no one in the U.S. is more well-positioned to wear the fierce cancer fighter label than McCain, some patients and survivors say it exemplifies how even well-intentioned observers can rely on stock phrases that can sometimes do more harm than good.
Simon, Stacy. "New Website to Help Cancer Survivors Manage Health." American Cancer Society, October 26, 2016.
Springboard Beyond Cancer provides survivors with online tools to manage side effects from cancer treatment, cope with stress, improve healthy behaviors, communicate better with their health care teams, and ask for support from family and friends.
Snapp, Janet; Dori Klemanski. "Survivorship movement helps people learn to live well with cancer." STAT, October 11, 2016.
As cancer treatments improve, that number will grow, and millions more will have to learn to live a life forever altered by cancer.
Bryla, Jacy. "Cancer Presents Complex Workplace Challenges—According to IBI Research." Integrated Benefits Institute, March 26, 2014.
Cancer typically costs employers about $19,000 annually per 100 employees in lost work time and medical treatments. Lost work time and underperformance at work (presenteeism) due to cancer costs employers $10,000 per 100 workers—more than half of the total costs associated with cancer—and medical and pharmacy treatments cost about $9,100. Employees with cancer are absent 3.8 more days per year than workers without cancer, and also lose the equivalent of 1.8 more days per year to presenteeism.